Thomas Hong | Manager-Investor Communications |
Jacqueline Shea | President and Chief Executive Officer |
Michael Sumner | Chief Medical Officer |
Peter Kies | Chief Financial Officer |
Hartaj Singh | Oppenheimer |
Charlie Young | Bank of America |
Yi Chen | H.C. Wainwright |
Good afternoon, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Good afternoon, and thank you for joining the Inovio 2022 Fourth Quarter and Full Year Financial Results Conference Call.